Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin vs Posaconazole for Fungal Prophylaxis in Leukemia/MDS
NCT01200355Phase 4Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2010
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of micafungin in invasive fungal infection (IFI), sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 2010; status: completed.
02
Drugs
micafungin
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT01200355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01200355.